Tim Littlewood

A phase 2 trial of the FLT3 inhibitor lestaurtinib (CEP701) as first-line treatment for older patients with acute myeloid leukemia not considered fit for intensive chemotherapy

Steven Knapper, Alan K. Burnett, Tim Littlewood et al. · Blood · 2006 · 413 citations · Full text

Medicine, Oncology, Pharmacology +10

Guideline for the laboratory diagnosis of functional iron deficiency

Wayne Thomas, Rod F Hinchliffe, Carol Briggs et al. · British Journal of Haematology · 2013 · 396 citations · Full text

Medicine, Hematology, Physiology +17

The Role of the Iron Transporter ABCB7 in Refractory Anemia with Ring Sideroblasts

Jacqueline Boultwood, Andrea Pellagatti, Maryam Nikpour et al. · PLoS ONE · 2008 · 133 citations · Full text

Medicine, Genetics, Hematology +17

The level of haemoglobin in anaemic cancer patients correlates positively with quality of life

M. Lind, C. C. Vernon, Deborah Cruickshank et al. · British Journal of Cancer · 2002 · 118 citations · Full text

Medicine, Hematology, Oncology +12

Outcome of second allogeneic transplants using reduced-intensity conditioning following relapse of haematological malignancy after an initial allogeneic transplant

Bronwen E. Shaw, G J Mufti, Stephen Mackinnon et al. · Bone Marrow Transplantation · 2008 · 111 citations

Medicine, Hematology, Immunology +12